Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock - Foreign
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
222,400
-
Shares change
-
+60,000
-
Total reported value, excl. options
-
$3,425,163
-
Value change
-
+$924,163
-
Number of buys
-
1
-
Price
-
$15.4
Significant Holders of Astellas Pharma Inc - Common Stock - Foreign as of Q1 2021
2 filings reported holding 006985383 - Astellas Pharma Inc - Common Stock - Foreign as of Q1 2021.
Astellas Pharma Inc - Common Stock - Foreign has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 222,400 shares
.
Largest 2 shareholders include Legato Capital Management LLC (162,400 shares) and PARADIGM ASSET MANAGEMENT CO LLC (60,000 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.